CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine

[ad_1] CSL Seqirus will deliver further H5N8 A/Astrakhan antigen to support the U.S. government’s pandemic preparedness activities This is the third influenza pandemic preparedness award to CSL Seqirus in the…

CSL Seqirus

[ad_1] Derived from the expression ‘securing health for all of us‘, CSL Seqirus has public health protection at its core. This reflects the promise of our parent company CSL, founded…